Home / Health / HRT Shortage Sparks Warning Against Self-Medication
HRT Shortage Sparks Warning Against Self-Medication
15 Oct
Summary
- Women are warned against self-medicating due to HRT medication shortages.
- Two major HRT patch brands, Estradot and FemSeven Conti, face supply disruptions.
- Healthcare professionals urge patients to consult GPs or pharmacists for alternatives.
Healthcare professionals are urging women not to self-medicate for menopause symptoms due to current shortages of certain Hormone Replacement Therapy (HRT) medications. Supply disruptions have been confirmed for Estradot transdermal and FemSeven Conti patches across the UK. These shortages are causing anxiety for patients who have found specific HRT preparations that effectively manage their symptoms.
Pharmacists emphasize the importance of seeking professional advice for alternative treatments, as switching brands without guidance can lead to side effects or reduced efficacy. A Serious Shortage Protocol (SSP) is in place for Estradot transdermal patches until January 8, 2027, allowing pharmacists to supply alternatives under specific conditions.
Patient support groups have noted that some women switching brands have experienced side effects, such as skin irritation or patches detaching. Experts advise seeking longer-term prescriptions and strictly avoiding sharing HRT medication, as what suits one individual may not be appropriate for another. The reliance on effective HRT for managing daily life and mental health is highlighted.
